South Korea - Lipid Modifying Medicine Use

Since 2014, South Korea Lipid Modifying Medicine Use was up 7% year on year. With 72.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 24 among other countries in Lipid Modifying Medicine Use. South Korea is overtaken by Latvia, which was number 23 with 80.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Estonia at 66.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.5% compared to 2018. United Kingdom, Belgium and Norway respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +15% per year, while Slovakia was the worst growing country at -7% per year.

Loading...

Date Units (Defined Daily Dosage) Per Thousand Persons Per Day
2019 72.90
2018 70.30
2017 68.70
2016 64.90
2015 58.80
Download all data from 2008 to 2019

How does South Korea rank in Lipid Modifying Medicine Use?

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Denmark
160 2019 +3.5 % +3.8 % View data
2 #2
United Kingdom
153 2019 +1.7 % +2.3 % View data
23 #23
Latvia
80 2019 +3.5 % +7.4 % View data
24 #24
South Korea
73 2019 +3.7 % +7.0 % View data
25 #25
Estonia
67 2019 +2.9 % +7.0 % View data
Compare all 28 countries

Go Top